Ho Carole sold DNLI
August 12, 2025 · Form 4 insider transaction
Ho Carole sold 2,937 shares of Denali Therapeutics Inc. at $13.58 per share, a transaction worth $39.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.; The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $13.34 to $13.58 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.; Includes 128,405 Unvested RSUs.